GeneOnline Interview | Dr. Potria Lin

CDMO Opportunities Amid Global Supply Chain Restructuring

Dr. Portia Lin – Senior VP & CBO, EirGenix, 11. 06. 2026

Dr. Portia Lin, Senior Vice President and Chief Business Officer of EirGenix, discusses how global supply chain realignment is reshaping the biologics CDMO industry and the company’s dual-engine strategy combining CDMO services with biosimilar development. Lin explores the differing priorities of biotech startups and large pharmaceutical companies, opportunities in the US and Japanese markets, and the evolution of CDMOs into strategic partners. She also outlines EirGenix’s approach to flexible collaboration, cross-border licensing, and long-term value creation.

Read the full article

Dr. Portia Lin – Senior VP & CBO, EirGenix